EIS
Price
Price
CHART BY
Historical dividends and forecast
EIS has so far distributed $0.0365 in 2024. The next dividend will be paid on 07.06.2025
CHART BY
Frequently asked questions
What is EIS's market capitalization?
What is EIS's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for EIS?
What are the analyst ratings and target price for EIS's stock?
What is EIS's revenue over the trailing twelve months?
What is the EBITDA for EIS?
What is the free cash flow of EIS?
What is the free float of EIS's shares?
Financials
- Market Cap
- $950.47M
- EPS (TTM)
- $0.147
- Free Float
- 128.61M
- P/E ratio (TTM)
- 9.43
- Revenue (TTM)
- $245.18M
- EBITDA (TTM)
- $22.50M
- Free Cashflow (TTM)
- $45.42M
Pricing
- 52W span
- $1.085$1.958
Analyst Ratings
The price target is $0.0929 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS is a holding company, which engages in the investment and management business. It operates through the Health and Real Estate Development segments. The Health segment is the production and sale of human health and veterinary medicine. The Real Estate Development segment is the sale and lease of properties and lands. The company was founded by Mehmet Nejat Eczacibasi, Melih Eczacibasi, Haluk Eczacibasi, Kemal Eczacibasi, and M. Sakir Eczacibas on October 24, 1951 and is headquartered in Istanbul, Turkey.
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- TRAECILC91E0
- Primary Ticker
- ECILC.E